New Process Makes Medical Research Easier
Wednesday, 28 October, 2009
NEW PROCESS MAKES MEDICAL
RESEARCH EASIER IN VICTORIA
Medical research into
potentially lifesaving treatments will be easier to conduct
in Victoria as a result of a Brumby Labor Government review
of clinical trials.
The initiative streamlines the
ethical review process for multi-site trials meaning
researchers need only apply for one approval rather than
separate approval for each site and their research can begin
more quickly.
Announcing the new initiative as part of
the opening address today at the AusBiotech 2009 Conference
in Melbourne, Innovation Minister Gavin Jennings also
confirmed Melbourne will again host the AusBiotech
conference – the Asia-Pacific’s biggest biotechnology
event – in 2010 and 2012.
“The Brumby Labor
Government is taking action to make it easier for important
clinical trials to take place across the State which means
potentially lifesaving treatments will be available to
Victorians sooner,” Mr Jennings said.
“The new
approach allows pharmaceutical companies to undergo one
ethical review process for multi-site clinical trials rather
than having to apply for separate approvals from ethics
committees at each separate location
“Simplifying
and shortening the approval process for research will also
generate economic benefits for Victoria and provide a strong
incentive for international industry and researchers to
continue high quality research all over
Victoria.”
Health Minister Daniel Andrews welcomed
the initiative and said it would further build Victoria’s
reputation as a deliverer of pharmaceutical solutions to
global health problems.
“Victoria is at the
forefront of the fight against global illnesses such as
swine flu. This initiative will further position our health
system as a high quality and competitive place for clinical
trials while maintaining our high quality of ethical review
and patient safety,” Mr Andrews said.
“Worldwide
competition for attracting pharmaceutical industry
investment is tough, but Victoria has a first class health
system with an enviable reputation in medical
research.”
The streamlining initiative is part of
the $20 million Biotechnology Bridges program announced in
the 2008 Victorian Innovation Statement and will start on
November 16.
Mr Jennings said Melbourne was the ideal
place to hold the 2010 and 2012 AusBiotech Conferences. In
the past decade the Victorian Government has invested over
$3 billion in innovation-related initiatives which places
Victoria at the forefront of innovation research in
Australia.
He said an independent report by Deloitte,
released yesterday at AusBiotech, showed Victoria’s $620
million Science, Technology and Innovation initiative over
the past decade has created thousands of jobs and would
produce an economic benefit to the State of $1.7
billion.
ENDS